Chimera Investment (NYSE:CIM - Get Free Report) is expected to be issuing its Q1 2026 results before the market opens on Thursday, May 7th. Analysts expect the company to announce earnings of $0.5180 per share and revenue of $102.30 million for the quarter. Individuals can find conference call details on the company's upcoming Q1 2026 earning report page for the latest details on the call scheduled for Thursday, May 7, 2026 at 8:30 AM ET.
Chimera Investment (NYSE:CIM - Get Free Report) last released its earnings results on Wednesday, February 11th. The real estate investment trust reported $0.53 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.03. Chimera Investment had a net margin of 28.06% and a return on equity of 8.73%. The firm had revenue of $72.01 million during the quarter, compared to the consensus estimate of $80.77 million.
Chimera Investment Stock Down 1.3%
Chimera Investment stock opened at $13.55 on Thursday. Chimera Investment has a twelve month low of $11.67 and a twelve month high of $14.88. The firm has a 50 day moving average price of $13.26 and a 200-day moving average price of $12.93. The company has a market capitalization of $1.13 billion, a P/E ratio of 7.74 and a beta of 1.74. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 2.71.
Chimera Investment Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.80 dividend on an annualized basis and a dividend yield of 13.3%. This is an increase from Chimera Investment's previous quarterly dividend of $0.37. Chimera Investment's payout ratio is currently 102.86%.
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on the stock. Weiss Ratings downgraded shares of Chimera Investment from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Friday, March 20th. Wall Street Zen downgraded shares of Chimera Investment from a "hold" rating to a "sell" rating in a research report on Saturday, February 21st. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $14.50.
Read Our Latest Stock Analysis on CIM
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC increased its stake in Chimera Investment by 92.1% in the second quarter. Tower Research Capital LLC TRC now owns 7,140 shares of the real estate investment trust's stock valued at $99,000 after acquiring an additional 3,423 shares during the last quarter. BNP Paribas Financial Markets increased its stake in Chimera Investment by 59.2% in the second quarter. BNP Paribas Financial Markets now owns 7,686 shares of the real estate investment trust's stock valued at $107,000 after acquiring an additional 2,857 shares during the last quarter. Kestra Advisory Services LLC bought a new position in Chimera Investment in the fourth quarter valued at $105,000. Landscape Capital Management L.L.C. bought a new position in Chimera Investment in the fourth quarter valued at $129,000. Finally, WINTON GROUP Ltd bought a new position in Chimera Investment in the fourth quarter valued at $154,000. Institutional investors own 48.44% of the company's stock.
About Chimera Investment
(
Get Free Report)
Chimera Investment Corporation NYSE: CIM is a publicly traded real estate investment trust that specializes in investing in residential mortgage assets. The company's portfolio primarily consists of agency and non-agency residential mortgage-backed securities, whole loan residential mortgages and other mortgage-related assets. As a REIT, Chimera Investment aims to generate attractive risk-adjusted returns through its focus on high-quality collateral and disciplined risk management.
The firm's core business activities include identifying and acquiring portfolios of residential mortgage loans and securities from financial institutions and in the secondary market.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Chimera Investment, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chimera Investment wasn't on the list.
While Chimera Investment currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.